Results 101 to 110 of about 483,267 (209)
T Felekis1, I Asproudis1, K Katsanos2, EV Tsianos21University Eye Clinic of Ioannina, Ioannina, Greece; 2First Department of Internal Medicine, University Hospital of Ioannina, Ioannina, GreeceAbstract: A 51-year-old male was referred to the University ...
Tsianos EV +3 more
core
A 46-year-old patient diagnosed with rheumatoid arthritis underwent cataract surgery for a subcapsular cataract. Perioperative intraocular pressure (IOP) increased after two sideport incisions.
Dilbade Yıldız Ekinci +3 more
core +1 more source
Anterior ischemic optic neuropathy (AION) is a common cause of visual loss in patients over 50 years of age. Optical coherence tomography has provided new information which may have implications regarding future approaches to ...
Daniel Lopez Felipe +13 more
core +1 more source
Carotid artery dissection linked to intermittent apnoeic swimming: A case–control study
Abstract Internal carotid artery (ICA) dissection is a rare and potentially devastating cause of cerebral ischaemia, initiated by an intimal tear or rupture of the vasa vasorum, that can lead to an intraluminal thrombus, vascular stenosis, occlusion, or dissecting aneurysm formation.
Damian M. Bailey +14 more
wiley +1 more source
Tacrolimus associated Ischemic Optic Neuropathy
Tacrolimus is widely used immunosuppressant and though neurotoxicity is well recognized as a side effect, the risk of toxic optic neuropathy is low and described in a few case reports.
Shuai-Chun Lin; Hang Pham; Sangeeta Khanna
core
Enhancement of the optic nerve is occasionally noted in patients with arteritic ischemic optic neuropathy (ION) and non-arteritic anterior ION. We report a rare case of bilateral optic nerve enhancement in hypotension-related posterior ION (PION)
Mehdi Tavakoli; Michael S. Vaphides +1 more
core
Abstract figure legend Mitochondria are highly dynamic organelles that continuously remodel their architecture through coordinated cycles of fusion and fission. This review examines the four key GTPases that orchestrate mitochondrial dynamics in mammals: MFN1, MFN2, OPA1, and DRP1.
Rémi Chaney +4 more
wiley +1 more source
Visual Fields in the Ischemic Optic Neuropathy Treatment Trial at Baseline and Follow-up
A computerized system was developed to analyze Humphrey visual fields obtained from patients with non- arteritic anterior ischemic optic neuropathy (NAION) and enrolled in the Ischemic Optic Neuropathy Decompression Trial (IONDT)
Steven E. Feldon, MD; Lori Levin, MS; Roberta W. Scherer, PhD; Anthony Arnold, MD; Sophia M. Chung, MD; Lenworth Johnson, MD; Gregory Kosmorsky, DO; Steven A. Newman, MD; Joanne Katz, PhD; Patricia Langenberg, PhD; P. David Wilson, PhD; Shalom E. Kelman, MD; Kay Dickersin, PhD (for the Ischemic Optic Neuropathy Decompression Trial Group)
core
The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci +25 more
wiley +1 more source
POEMS Syndrome: 2026 Update on Diagnosis, Risk‐Stratification, and Management
ABSTRACT Disease Overview POEMS syndrome is a life‐threatening syndrome due to an underlying plasma cell neoplasm. The major criteria for the syndrome are polyneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular endothelial growth factor, and the presence of Castleman disease.
Angela Dispenzieri
wiley +1 more source

